Healthcare Cold Chain Monitoring Market: Forecast till 2027
出 版 商：Market Research Future
出版日期：2022/02/10
頁 數：100頁
文件格式：PDF
價 格：
USD 4,450 (Single-User License)
USD 6,250 (Global-User License)
USD 6,250 (Global-User License)
Healthcare Cold Chain Monitoring Market—Forecast till 2027
Market Overview
As per the MRFR statistics, the Healthcare cold chain monitoring market is anticipated to exhibit a significant CAGR of over 12.2% to surpass USD 5,345.6 million during the review period. The market expansion is relied upon to be biologics, like those utilized in quality treatment. Further developing the current inventory chains to guarantee an emphasis on exact temperature monitoring, cold chain monitoring, and information logging can assist you with saving the trustworthiness of your item, setting aside cash, and giving better medicines to patients.
The healthcare cold chain monitoring market is expected to register healthy market growth owing to the rising requirement for cold chain monitoring in the healthcare industry and the growing use of IoT in the healthcare sector. Cold chain strategies in the medical care area help screen and shield bundles from harm because of temperature changes. Cold chain monitoring is fundamental for medical services as it guarantees that the capacity of medications and different medications is kept up with at an ideal temperature till they arrive at their objections. Numerous life sciences merchandise, like prescriptions, some clinical hardware, organs, and examples, require temperature-controlled capacity and dissemination to keep up with sub-atomic security, safeguarding, and augmentation of valuable life.
Segment Overview
The global healthcare cold chain monitoring market has been classified into components, temperature type, product, end-user, and region.
Based on the component segment, the market is divided into hardware and software. The hardware segment is subclassified into sensors, data loggers, real-time monitoring devices, RFID devices, resistance temperature detectors, and others. The software segment is subdivided into cloud-based and on-premises.
In terms of temperature type, the global market is bifurcated into chilled and frozen. The product segment categorizes the healthcare cold chain monitoring market into vaccines, biopharmaceuticals, clinical trial materials, and others. Based on end-user, the market has been categorized into biopharmaceutical companies, hospitals & clinics, research institutes, and others.
Regional Analysis
Geographically, the healthcare cold chain monitoring market is classified into Asia-Pacific, North America, Europe, and the Rest of the World.
North America is likely to drive the global market owing to the largest market share of 34.84% in 2020. The regional market growth is driven by the rising demand for customized storage and transportation to ensure the effectiveness of healthcare products, and the rising focus of organizations on improving business agility.
Europe is anticipated to register as the largest market owing to the adoption of cold chain monitoring solutions by the midsize healthcare industry. The Asia- Pacific market for healthcare cold chain monitoring is driven by the growing demand for these cloud solutions in biopharmaceutical companies.
Major Players
The major players in the healthcare cold chain monitoring market include Carrier (US), Monnit Corporation (US), Temptime Corporation (US), Cold Chain Technologies (US), Dickson (US), Spotsee (US), Berlinger & Co. AG (Switzerland), Testo SE & Co. KGaA (Germany), Emerson (US), Signatrol (UK), Haier Biomedical (Shandong), Rotronic (Switzerland), Elpro (Switzerland), Controlant (Iceland), Roambee Corporation (California), OnAsset Intelligence, Inc. (US), and Tive (US).
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.
Market Overview
As per the MRFR statistics, the Healthcare cold chain monitoring market is anticipated to exhibit a significant CAGR of over 12.2% to surpass USD 5,345.6 million during the review period. The market expansion is relied upon to be biologics, like those utilized in quality treatment. Further developing the current inventory chains to guarantee an emphasis on exact temperature monitoring, cold chain monitoring, and information logging can assist you with saving the trustworthiness of your item, setting aside cash, and giving better medicines to patients.
The healthcare cold chain monitoring market is expected to register healthy market growth owing to the rising requirement for cold chain monitoring in the healthcare industry and the growing use of IoT in the healthcare sector. Cold chain strategies in the medical care area help screen and shield bundles from harm because of temperature changes. Cold chain monitoring is fundamental for medical services as it guarantees that the capacity of medications and different medications is kept up with at an ideal temperature till they arrive at their objections. Numerous life sciences merchandise, like prescriptions, some clinical hardware, organs, and examples, require temperature-controlled capacity and dissemination to keep up with sub-atomic security, safeguarding, and augmentation of valuable life.
Segment Overview
The global healthcare cold chain monitoring market has been classified into components, temperature type, product, end-user, and region.
Based on the component segment, the market is divided into hardware and software. The hardware segment is subclassified into sensors, data loggers, real-time monitoring devices, RFID devices, resistance temperature detectors, and others. The software segment is subdivided into cloud-based and on-premises.
In terms of temperature type, the global market is bifurcated into chilled and frozen. The product segment categorizes the healthcare cold chain monitoring market into vaccines, biopharmaceuticals, clinical trial materials, and others. Based on end-user, the market has been categorized into biopharmaceutical companies, hospitals & clinics, research institutes, and others.
Regional Analysis
Geographically, the healthcare cold chain monitoring market is classified into Asia-Pacific, North America, Europe, and the Rest of the World.
North America is likely to drive the global market owing to the largest market share of 34.84% in 2020. The regional market growth is driven by the rising demand for customized storage and transportation to ensure the effectiveness of healthcare products, and the rising focus of organizations on improving business agility.
Europe is anticipated to register as the largest market owing to the adoption of cold chain monitoring solutions by the midsize healthcare industry. The Asia- Pacific market for healthcare cold chain monitoring is driven by the growing demand for these cloud solutions in biopharmaceutical companies.
Major Players
The major players in the healthcare cold chain monitoring market include Carrier (US), Monnit Corporation (US), Temptime Corporation (US), Cold Chain Technologies (US), Dickson (US), Spotsee (US), Berlinger & Co. AG (Switzerland), Testo SE & Co. KGaA (Germany), Emerson (US), Signatrol (UK), Haier Biomedical (Shandong), Rotronic (Switzerland), Elpro (Switzerland), Controlant (Iceland), Roambee Corporation (California), OnAsset Intelligence, Inc. (US), and Tive (US).
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
1.1 MARKET SUMMARY
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
3 RESEARCH METHODOLOGY
4 MARKET DYNAMICS
4.1 INTRODUCTION
4.2 DRIVERS
4.2.1 GROWING NEED FOR COLD CHAIN MONITORING IN THE HEALTHCARE SECTOR
4.2.2 INCREASED USE OF IOT TECHNOLOGY IN THE HEALTHCARE SECTOR
4.2.3 DRIVERS IMPACT ANALYSIS
4.3 OPPORTUNITIES
4.3.1 RISING DEMAND FOR WAREHOUSE AUTOMATION IN COLD CHAIN STORAGE
4.3.2 GROWING INVESTMENTS IN PHARMACEUTICAL COLD CHAIN
4.4 CHALLENGES
4.4.1 MAINTAINING TEMPERATURE INTEGRITY THROUGHOUT THE SUPPLY CHAIN
5 MARKET FACTOR ANALYSIS
5.1 SUPPLY CHAIN ANALYSIS
5.1.1 COMPONENT MANUFACTURERS
5.1.2 SOFTWARE DEVELOPERS
5.1.3 SYSTEM INTEGRATORS
5.1.4 SOLUTION/SERVICE PROVIDERS
5.1.5 END USERS
5.2 PORTER'S FIVE FORCES MODEL
5.2.1 THREAT OF NEW ENTRANTS
5.2.2 BARGAINING POWER OF SUPPLIERS
5.2.3 BARGAINING POWER OF BUYERS
5.2.4 THREAT OF SUBSTITUTES
5.2.5 INTENSITY OF RIVALRY
6 GLOBAL HEALTHCARE COLD CHAIN MONITORING MARKET, BY COMPONENT
6.1 OVERVIEW
6.1.1 MARKET ESTIMATES & FORECAST, 2019–2027
6.1.2 HARDWARE
6.1.2.1 SENSORS
6.1.2.2 DATA LOGGERS
6.1.2.3 REAL-TIME MONITORING DEVICES
6.1.2.4 RFID DEVICES
6.1.2.5 RESISTANCE TEMPERATURE DETECTORS
6.1.2.6 OTHERS
6.1.3 SOFTWARE
6.1.3.1 CLOUD BASED
6.1.3.2 ON-PREMISES
7 GLOBAL HEALTHCARE COLD CHAIN MONITORING MARKET, BY TEMPERATURE TYPE
7.1 OVERVIEW
7.1.1 MARKET ESTIMATES & FORECAST, 2019–2027
7.1.2 FROZEN
7.1.3 CHILLED
8 GLOBAL HEALTHCARE COLD CHAIN MONITORING MARKET, BY PRODUCT
8.1 OVERVIEW
8.1.1 MARKET ESTIMATES & FORECAST, 2019–2027
8.1.2 VACCINES
8.1.3 BIOPHARMACEUTICALS
8.1.4 CLINICAL TRIAL MATERIALS
8.1.5 OTHERS
9 GLOBAL HEALTHCARE COLD CHAIN MONITORING MARKET, BY END-USER
9.1 OVERVIEW
9.1.1 MARKET ESTIMATES & FORECAST, 2019–2027
9.1.2 BIOPHARMACEUTICAL COMPANIES
9.1.3 HOSPITAL & CLINICS
9.1.4 RESEARCH INSTITUTES
9.1.5 OTHERS
10 GLOBAL HEALTHCARE COLD CHAIN MONITORING MARKET, BY REGION
10.1 OVERVIEW
10.1.1 MARKET ESTIMATES & FORECAST, 2019–2027
10.2 NORTH AMERICA
10.2.1 US
10.2.2 CANADA
10.2.3 MEXICO
10.3 EUROPE
10.3.1 UK
10.3.2 GERMANY
10.3.3 FRANCE
10.3.4 ITALY
10.3.5 SPAIN
10.3.6 RUSSIA
10.3.7 NETHERLAND
10.3.8 FINLAND
10.3.9 BELGIUM
10.3.10 POLAND
10.3.11 REST OF EUROPE
10.4 ASIA-PACIFIC
10.4.1 CHINA
10.4.2 JAPAN
10.4.3 INDIA
10.4.4 REST OF ASIA-PACIFIC
10.5 REST OF THE WORLD
10.5.1 MIDDLE EAST & AFRICA
10.5.2 CENTRAL & SOUTH AMERICA
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 MARKET SHARE ANALYSIS
11.3 COMPETITIVE BENCHMARKING
11.4 COMPETITOR DASHBOARD
11.5 KEY DEVELOPMENTS & GROWTH STRATEGIES
11.5.1 PRODUCT LAUNCHES/PRODUCT DEVELOPMENTS/SERVICE DEPLOYMENTS
11.5.2 MERGERS&ACQUISITIONS/EXPANSIONS/PARTNERSHIPS/JOINT VENTURES
12 COMPANY PROFILE
12.1 CARRIER
12.1.1 COMPANY OVERVIEW
12.1.2 FINANCIAL OVERVIEW
12.1.3 SOLUTIONS OFFERED
12.1.4 KEY DEVELOPMENTS
12.1.5 SWOT ANALYSIS
12.1.6 KEY STRATEGIES
12.2 MONNIT CORPORATION
12.2.1 COMPANY OVERVIEW
12.2.2 FINANCIAL OVERVIEW
12.2.3 SOLUTIONS OFFERED
12.2.4 PRODUCTS OFFERED
12.2.5 KEY DEVELOPMENTS
12.2.6 SWOT ANALYSIS
12.2.7 KEY STRATEGIES
12.3 BERLINGER & CO. AG
12.3.1 COMPANY OVERVIEW
12.3.2 FINANCIAL OVERVIEW
12.3.3 SOLUTIONS OFFERED
12.3.4 KEY DEVELOPMENTS
12.3.5 SWOT ANALYSIS
12.3.6 KEY STRATEGIES
12.4 TESTO SE & CO. KGAA
12.4.1 COMPANY OVERVIEW
12.4.2 FINANCIAL OVERVIEW
12.4.3 PRODUCTS OFFERED
12.4.4 KEY DEVELOPMENTS
12.4.5 SWOT ANALYSIS
12.4.6 KEY STRATEGIES
12.5 EMERSON ELECTRIC CO.
12.5.1 COMPANY OVERVIEW
12.5.2 FINANCIAL OVERVIEW
12.5.3 PRODUCTS OFFERED
12.5.4 KEY DEVELOPMENTS
12.5.5 SWOT ANALYSIS
12.5.6 KEY STRATEGIES
12.6 SIGNATROL
12.6.1 COMPANY OVERVIEW
12.6.2 FINANCIAL OVERVIEW
12.6.3 PRODUCTS OFFERED
12.6.4 KEY DEVELOPMENTS
12.6.5 KEY STRATEGIES
12.7 HAIER BIOMEDICAL
12.7.1 COMPANY OVERVIEW
12.7.2 FINANCIAL OVERVIEW
12.7.3 PRODUCTS OFFERED
12.7.4 KEY DEVELOPMENTS
12.7.5 KEY STRATEGIES
12.8 TEMPTIME CORPORATION
12.8.1 COMPANY OVERVIEW
12.8.2 FINANCIAL OVERVIEW
12.8.3 PRODUCTS OFFERED
12.8.4 KEY DEVELOPMENTS
12.8.5 KEY STRATEGIES
12.9 COLD CHAIN TECHNOLOGIES
12.9.1 COMPANY OVERVIEW
12.9.2 FINANCIAL OVERVIEW
12.9.3 PRODUCTS OFFERED
12.9.4 KEY DEVELOPMENTS
12.9.5 KEY STRATEGIES
12.10 DICKSON
12.10.1 COMPANY OVERVIEW
12.10.2 FINANCIAL OVERVIEW
12.10.3 PRODUCTS OFFERED
12.10.4 KEY DEVELOPMENTS
12.11 SPOTSEE
12.11.1 COMPANY OVERVIEW
12.11.2 FINANCIAL OVERVIEW
12.11.3 PRODUCTS OFFERED
12.11.4 KEY DEVELOPMENT
12.11.5 KEY STRATEGIES
12.12 ROTRONIC AG
12.12.1 COMPANY OVERVIEW
12.12.2 FINANCIAL OVERVIEW
12.12.3 PRODUCTS OFFERED
12.12.4 KEY DEVELOPMENTS
12.12.5 KEY STRATEGIES
12.13 ELPRO-BUCHS AG
12.13.1 COMPANY OVERVIEW
12.13.2 FINANCIAL OVERVIEW
12.13.3 SOLUTIONS OFFERED
12.13.4 KEY DEVELOPMENTS
12.13.5 SWOT ANALYSIS
12.13.6 KEY STRATEGIES
12.14 CONTROLANT
12.14.1 COMPANY OVERVIEW
12.14.2 FINANCIAL OVERVIEW
12.14.3 SOLUTIONS OFFERED
12.14.4 KEY DEVELOPMENTS
12.14.5 SWOT ANALYSIS
12.14.6 KEY STRATEGIES
12.15 ROAMBEE CORPORATION
12.15.1 COMPANY OVERVIEW
12.15.2 FINANCIAL OVERVIEW
12.15.3 SERVICES OFFERED
12.15.4 KEY DEVELOPMENTS
12.15.5 SWOT ANALYSIS
12.15.6 KEY STRATEGIES
12.16 ONASSET INTELLIGENCE, INC.
12.16.1 COMPANY OVERVIEW
12.16.2 FINANCIAL OVERVIEW
12.16.3 PRODUCTS OFFERED
12.16.4 KEY DEVELOPMENTS
12.16.5 SWOT ANALYSIS
12.16.6 KEY STRATEGIES
12.17 TIVE
12.17.1 COMPANY OVERVIEW
12.17.2 FINANCIAL OVERVIEW
12.17.3 SOLUTIONS OFFERED
12.17.4 KEY DEVELOPMENTS
12.17.5 SWOT ANALYSIS
12.17.6 KEY STRATEGIES
?
?
1 EXECUTIVE SUMMARY
1.1 MARKET SUMMARY
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
3 RESEARCH METHODOLOGY
4 MARKET DYNAMICS
4.1 INTRODUCTION
4.2 DRIVERS
4.2.1 GROWING NEED FOR COLD CHAIN MONITORING IN THE HEALTHCARE SECTOR
4.2.2 INCREASED USE OF IOT TECHNOLOGY IN THE HEALTHCARE SECTOR
4.2.3 DRIVERS IMPACT ANALYSIS
4.3 OPPORTUNITIES
4.3.1 RISING DEMAND FOR WAREHOUSE AUTOMATION IN COLD CHAIN STORAGE
4.3.2 GROWING INVESTMENTS IN PHARMACEUTICAL COLD CHAIN
4.4 CHALLENGES
4.4.1 MAINTAINING TEMPERATURE INTEGRITY THROUGHOUT THE SUPPLY CHAIN
5 MARKET FACTOR ANALYSIS
5.1 SUPPLY CHAIN ANALYSIS
5.1.1 COMPONENT MANUFACTURERS
5.1.2 SOFTWARE DEVELOPERS
5.1.3 SYSTEM INTEGRATORS
5.1.4 SOLUTION/SERVICE PROVIDERS
5.1.5 END USERS
5.2 PORTER'S FIVE FORCES MODEL
5.2.1 THREAT OF NEW ENTRANTS
5.2.2 BARGAINING POWER OF SUPPLIERS
5.2.3 BARGAINING POWER OF BUYERS
5.2.4 THREAT OF SUBSTITUTES
5.2.5 INTENSITY OF RIVALRY
6 GLOBAL HEALTHCARE COLD CHAIN MONITORING MARKET, BY COMPONENT
6.1 OVERVIEW
6.1.1 MARKET ESTIMATES & FORECAST, 2019–2027
6.1.2 HARDWARE
6.1.2.1 SENSORS
6.1.2.2 DATA LOGGERS
6.1.2.3 REAL-TIME MONITORING DEVICES
6.1.2.4 RFID DEVICES
6.1.2.5 RESISTANCE TEMPERATURE DETECTORS
6.1.2.6 OTHERS
6.1.3 SOFTWARE
6.1.3.1 CLOUD BASED
6.1.3.2 ON-PREMISES
7 GLOBAL HEALTHCARE COLD CHAIN MONITORING MARKET, BY TEMPERATURE TYPE
7.1 OVERVIEW
7.1.1 MARKET ESTIMATES & FORECAST, 2019–2027
7.1.2 FROZEN
7.1.3 CHILLED
8 GLOBAL HEALTHCARE COLD CHAIN MONITORING MARKET, BY PRODUCT
8.1 OVERVIEW
8.1.1 MARKET ESTIMATES & FORECAST, 2019–2027
8.1.2 VACCINES
8.1.3 BIOPHARMACEUTICALS
8.1.4 CLINICAL TRIAL MATERIALS
8.1.5 OTHERS
9 GLOBAL HEALTHCARE COLD CHAIN MONITORING MARKET, BY END-USER
9.1 OVERVIEW
9.1.1 MARKET ESTIMATES & FORECAST, 2019–2027
9.1.2 BIOPHARMACEUTICAL COMPANIES
9.1.3 HOSPITAL & CLINICS
9.1.4 RESEARCH INSTITUTES
9.1.5 OTHERS
10 GLOBAL HEALTHCARE COLD CHAIN MONITORING MARKET, BY REGION
10.1 OVERVIEW
10.1.1 MARKET ESTIMATES & FORECAST, 2019–2027
10.2 NORTH AMERICA
10.2.1 US
10.2.2 CANADA
10.2.3 MEXICO
10.3 EUROPE
10.3.1 UK
10.3.2 GERMANY
10.3.3 FRANCE
10.3.4 ITALY
10.3.5 SPAIN
10.3.6 RUSSIA
10.3.7 NETHERLAND
10.3.8 FINLAND
10.3.9 BELGIUM
10.3.10 POLAND
10.3.11 REST OF EUROPE
10.4 ASIA-PACIFIC
10.4.1 CHINA
10.4.2 JAPAN
10.4.3 INDIA
10.4.4 REST OF ASIA-PACIFIC
10.5 REST OF THE WORLD
10.5.1 MIDDLE EAST & AFRICA
10.5.2 CENTRAL & SOUTH AMERICA
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 MARKET SHARE ANALYSIS
11.3 COMPETITIVE BENCHMARKING
11.4 COMPETITOR DASHBOARD
11.5 KEY DEVELOPMENTS & GROWTH STRATEGIES
11.5.1 PRODUCT LAUNCHES/PRODUCT DEVELOPMENTS/SERVICE DEPLOYMENTS
11.5.2 MERGERS&ACQUISITIONS/EXPANSIONS/PARTNERSHIPS/JOINT VENTURES
12 COMPANY PROFILE
12.1 CARRIER
12.1.1 COMPANY OVERVIEW
12.1.2 FINANCIAL OVERVIEW
12.1.3 SOLUTIONS OFFERED
12.1.4 KEY DEVELOPMENTS
12.1.5 SWOT ANALYSIS
12.1.6 KEY STRATEGIES
12.2 MONNIT CORPORATION
12.2.1 COMPANY OVERVIEW
12.2.2 FINANCIAL OVERVIEW
12.2.3 SOLUTIONS OFFERED
12.2.4 PRODUCTS OFFERED
12.2.5 KEY DEVELOPMENTS
12.2.6 SWOT ANALYSIS
12.2.7 KEY STRATEGIES
12.3 BERLINGER & CO. AG
12.3.1 COMPANY OVERVIEW
12.3.2 FINANCIAL OVERVIEW
12.3.3 SOLUTIONS OFFERED
12.3.4 KEY DEVELOPMENTS
12.3.5 SWOT ANALYSIS
12.3.6 KEY STRATEGIES
12.4 TESTO SE & CO. KGAA
12.4.1 COMPANY OVERVIEW
12.4.2 FINANCIAL OVERVIEW
12.4.3 PRODUCTS OFFERED
12.4.4 KEY DEVELOPMENTS
12.4.5 SWOT ANALYSIS
12.4.6 KEY STRATEGIES
12.5 EMERSON ELECTRIC CO.
12.5.1 COMPANY OVERVIEW
12.5.2 FINANCIAL OVERVIEW
12.5.3 PRODUCTS OFFERED
12.5.4 KEY DEVELOPMENTS
12.5.5 SWOT ANALYSIS
12.5.6 KEY STRATEGIES
12.6 SIGNATROL
12.6.1 COMPANY OVERVIEW
12.6.2 FINANCIAL OVERVIEW
12.6.3 PRODUCTS OFFERED
12.6.4 KEY DEVELOPMENTS
12.6.5 KEY STRATEGIES
12.7 HAIER BIOMEDICAL
12.7.1 COMPANY OVERVIEW
12.7.2 FINANCIAL OVERVIEW
12.7.3 PRODUCTS OFFERED
12.7.4 KEY DEVELOPMENTS
12.7.5 KEY STRATEGIES
12.8 TEMPTIME CORPORATION
12.8.1 COMPANY OVERVIEW
12.8.2 FINANCIAL OVERVIEW
12.8.3 PRODUCTS OFFERED
12.8.4 KEY DEVELOPMENTS
12.8.5 KEY STRATEGIES
12.9 COLD CHAIN TECHNOLOGIES
12.9.1 COMPANY OVERVIEW
12.9.2 FINANCIAL OVERVIEW
12.9.3 PRODUCTS OFFERED
12.9.4 KEY DEVELOPMENTS
12.9.5 KEY STRATEGIES
12.10 DICKSON
12.10.1 COMPANY OVERVIEW
12.10.2 FINANCIAL OVERVIEW
12.10.3 PRODUCTS OFFERED
12.10.4 KEY DEVELOPMENTS
12.11 SPOTSEE
12.11.1 COMPANY OVERVIEW
12.11.2 FINANCIAL OVERVIEW
12.11.3 PRODUCTS OFFERED
12.11.4 KEY DEVELOPMENT
12.11.5 KEY STRATEGIES
12.12 ROTRONIC AG
12.12.1 COMPANY OVERVIEW
12.12.2 FINANCIAL OVERVIEW
12.12.3 PRODUCTS OFFERED
12.12.4 KEY DEVELOPMENTS
12.12.5 KEY STRATEGIES
12.13 ELPRO-BUCHS AG
12.13.1 COMPANY OVERVIEW
12.13.2 FINANCIAL OVERVIEW
12.13.3 SOLUTIONS OFFERED
12.13.4 KEY DEVELOPMENTS
12.13.5 SWOT ANALYSIS
12.13.6 KEY STRATEGIES
12.14 CONTROLANT
12.14.1 COMPANY OVERVIEW
12.14.2 FINANCIAL OVERVIEW
12.14.3 SOLUTIONS OFFERED
12.14.4 KEY DEVELOPMENTS
12.14.5 SWOT ANALYSIS
12.14.6 KEY STRATEGIES
12.15 ROAMBEE CORPORATION
12.15.1 COMPANY OVERVIEW
12.15.2 FINANCIAL OVERVIEW
12.15.3 SERVICES OFFERED
12.15.4 KEY DEVELOPMENTS
12.15.5 SWOT ANALYSIS
12.15.6 KEY STRATEGIES
12.16 ONASSET INTELLIGENCE, INC.
12.16.1 COMPANY OVERVIEW
12.16.2 FINANCIAL OVERVIEW
12.16.3 PRODUCTS OFFERED
12.16.4 KEY DEVELOPMENTS
12.16.5 SWOT ANALYSIS
12.16.6 KEY STRATEGIES
12.17 TIVE
12.17.1 COMPANY OVERVIEW
12.17.2 FINANCIAL OVERVIEW
12.17.3 SOLUTIONS OFFERED
12.17.4 KEY DEVELOPMENTS
12.17.5 SWOT ANALYSIS
12.17.6 KEY STRATEGIES
?
?
